Utah State University Institute of Antiviral Research Report Summary

The report from the Institute for Antiviral Research at Utah State University presents the results from testing the virucidal (Virucidal is defined by Merriam Webster’s dictionary as “having the capacity to or tending to destroy or inactivate viruses.”) effect of CofixRx Nasal Spray against SARS-CoV-2 (Covid-19), Influenza B (the flu), HRV-14 (common cold), and RSV.